{"id":31682,"date":"2026-02-08T21:28:04","date_gmt":"2026-02-08T21:28:04","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/cytokine-market-mordor\/"},"modified":"2026-10-09T19:51:52","modified_gmt":"2026-10-09T10:51:52","slug":"cytokine-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/cytokine-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026\ub144 &#8211; 2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cytokine-market-1767175652527-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/cytokine-market-size-image-1767175451891.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub9cc\uc131 \ubc0f \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc0ac\uc774\ud1a0\uce74\uc778 \uae30\ubc18 \uba74\uc5ed\uc694\ubc95\uc744 \ud65c\uc6a9\ud55c \uc885\uc591\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc7ac\uc870\ud569 \uacf5\ud559 \ubc0f \uc0dd\ubb3c\uacf5\uc815 \uae30\uc220\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.4 mRNA \uc778\ucf54\ub529, \uad6d\uc18c \uc804\ub2ec \uc0ac\uc774\ud1a0\uce74\uc778 \ubcf4\uc870\uc81c\uc758 \uad00\uc2ec \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870\ub97c \uc704\ud55c GMP \ub4f1\uae09 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\uc694<\/li>\n<li class=\"toc-level-3\">4.2.6 \ud76c\uadc0 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \ub3d9\uae09 \ucd5c\ucd08 \uc0ac\uc774\ud1a0\uce74\uc778 \uce58\ub8cc\uc81c\uc758 \ucd5c\uadfc FDA\/EMA \uc2b9\uc778<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \ubcf5\uc7a1\ud55c \uc815\uc81c \uc694\uad6c\uc0ac\ud56d<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc6a9\ub7c9 \uc81c\ud55c \ub3c5\uc131\uc73c\ub85c \uc778\ud55c \uc5c4\uaca9\ud55c \uaddc\uc81c \uc2ec\uc0ac<\/li>\n<li class=\"toc-level-3\">4.3.3 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\uc7c1\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc77c\ud68c\uc6a9 \uc0dd\ubb3c\uacf5\uc815 \uc18c\ubaa8\ud488\uc758 \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc778\ud130\ub8e8\ud0a8<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc885\uc591 \uad34\uc0ac \uc778\uc790 (TNF)<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc778\ud130\ud398\ub860<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc9d1\ub77d \uc790\uadf9 \uc778\uc790 (CSF)<\/li>\n<li class=\"toc-level-3\">5.1.5 \ucf00\ubaa8\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.1.6 \uc131\uc7a5 \uc778\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc554 \ubc0f \uc545\uc131 \uc885\uc591<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc790\uac00\uba74\uc5ed \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.3 \uac10\uc5fc\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc5fc\uc99d\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.3.3 \ubcd1\uc6d0 \ubc0f \uc9c4\ub2e8 \uc2e4\ud5d8\uc2e4<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00 (CRO)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uae30\ub2a5\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc804\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud56d\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc131\uc7a5 \ubc0f \ubd84\ud654 \uc778\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc18c\ub9e4 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \uc560\ube0c\ube44<\/li>\n<li class=\"toc-level-3\">6.3.2 \uc544\ud06c\ub85c\ubc14\uc774\uc624\uc2dc\uc2a4\ud15c\uc988<\/li>\n<li class=\"toc-level-3\">6.3.3 \uc554\uc820<\/li>\n<li class=\"toc-level-3\">6.3.4 \ubc14\uc774\uc624\uc820<\/li>\n<li class=\"toc-level-3\">6.3.5 \ubc14\uc774\uc624\ub798\ub4dc \ub798\ubc84\ub7ec\ud1a0\ub9ac\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.6 \ubc14\uc774\uc624\ud14c\ud06c\ub124 \/ R&amp;D \uc2dc\uc2a4\ud15c\uc988<\/li>\n<li class=\"toc-level-3\">6.3.7 \ube0c\ub9ac\uc2a4\ud1a8-\ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045<\/li>\n<li class=\"toc-level-3\">6.3.8 \uc77c\ub77c\uc774 \ub9b4\ub9ac<\/li>\n<li class=\"toc-level-3\">6.3.9 F. \ud638\ud504\ub9cc \ub77c \ub85c\uc288 Ltd<\/li>\n<li class=\"toc-level-3\">6.3.10 \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.11 \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8 (\uc580\uc13c)<\/li>\n<li class=\"toc-level-3\">6.3.12 \uba38\ud06c &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.13 \ubc00\ud14c\ub2c8 \ubc14\uc774\uc624\ud14d<\/li>\n<li class=\"toc-level-3\">6.3.14 \ub178\ubc14\ud2f0\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.15 \ud654\uc774\uc790<\/li>\n<li class=\"toc-level-3\">6.3.16 \ub9ac\uc81c\ub124\ub860<\/li>\n<li class=\"toc-level-3\">6.3.17 \uc0ac\ub178\ud53c<\/li>\n<li class=\"toc-level-3\">6.3.18 \ub2e4\ucf00\ub2e4<\/li>\n<li class=\"toc-level-3\">6.3.19 \uc368\ubaa8 \ud53c\uc154 \uc0ac\uc774\uc5b8\ud2f0\ud53d<\/li>\n<li class=\"toc-level-3\">6.3.20 \ubc84\ud14d\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uac1c\uc694: \uaddc\ubaa8, \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc758 \uaddc\ubaa8, \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc804\ub9dd\uc744 \uc0c1\uc138\ud788 \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc81c\ud488 \uc720\ud615(\uc778\ud130\ub8e8\ud0a8, \uc885\uc591 \uad34\uc0ac \uc778\uc790 \ub4f1), \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c(\uc554 \ubc0f \uc545\uc131 \uc885\uc591 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5 \ub4f1), \uae30\ub2a5(\uc804\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778 \ub4f1), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d \ub4f1) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8 \ub4f1)\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, \uc2dc\uc7a5 \uc608\uce21\uc740 USD \uac00\uce58\ub85c \uc81c\uacf5\ub429\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 2026\ub144 1,061\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144 1,494\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.08%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ub9cc\uc131 \uc9c8\ud658 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uc0ac\uc774\ud1a0\uce74\uc778 \uae30\ubc18 \uc554 \uba74\uc5ed \uce58\ub8cc\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870\ub97c \uc704\ud55c GMP \ub4f1\uae09 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\uc694 \uc99d\uac00\uc5d0 \ud798\uc785\uc740 \uac83\uc785\ub2c8\ub2e4. \ud604\uc7ac \uc885\uc591 \uad34\uc0ac \uc778\uc790(TNF)\ub97c \uc911\ud654\ud558\ub294 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uac00 \ub9e4\ucd9c\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\ub098, \ucc28\uc138\ub300 \uc778\ud130\ub8e8\ud0a8\uc740 \ub09c\uce58\uc131 \uc790\uac00\uba74\uc5ed \ubc0f \ud76c\uadc0 \uc5fc\uc99d\uc131 \uc9c8\ud658 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc784\uc0c1\uc801 \uad00\uc2ec\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc73c\ub85c\ub294 \uae30\uc874 TNF \uc5b5\uc81c\uc81c\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uce68\uc2dd, \ub300\ud615 \ubc14\uc774\uc624 \uc81c\uc57d\uc0ac\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \uacf5\uae09 \ud655\ubcf4\ub97c \uc704\ud55c \uc218\uc9c1 \ud1b5\ud569, \uadf8\ub9ac\uace0 \ub514\uc9c0\ud138 \uae30\ubc18\uc758 \uc7ac\ud0dd \ubc30\uc1a1 \ucc44\ub110\ub85c\uc758 \uc804\ud658\uc774 \uacbd\uc7c1 \uc5ed\ud559\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc0c8\ub85c\uc6b4 mRNA \uc778\ucf54\ub529 \uc0ac\uc774\ud1a0\uce74\uc778 \uad6c\uc870\ub294 \ub354 \ube60\ub978 \uc81c\uc870\uc640 \uad6d\uc18c \uba74\uc5ed \ud65c\uc131\ud654\ub97c \uc57d\uc18d\ud558\uc9c0\ub9cc, \uc9c0\uc18d\uc131\uacfc \uaddc\uc81c \ubd84\ub958\ub294 \uc5ec\uc804\ud788 \ubbf8\ud574\uacb0 \uacfc\uc81c\ub85c \ub0a8\uc544\uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8\uac00 2025\ub144 \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc73c\uba70(41.53%), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 10.79%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc774\uba70, \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 AbbVie Inc, Novartis AG, Johnson &#038; Johnson, Amgen, F. Hoffmann La Roche Ltd \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825 (\uc131\uc7a5 \ub3d9\ub825)<\/p>\n<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\ub825\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ub9cc\uc131 \ubc0f \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00 (+1.2% CAGR \uc601\ud5a5): \uc778\ud130\ub8e8\ud0a8-17, \uc778\ud130\ub8e8\ud0a8-23, TNF \uacbd\ub85c\ub97c \ucc28\ub2e8\ud558\ub294 \uc81c\uc81c \ucc98\ubc29\uc774 \uc99d\uac00\ud558\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub4c0\ud53c\ub8e8\ub9d9(Dupilumab)\uacfc \uac19\uc740 \uae30\uc874 \ud56d\uccb4 \uc758\uc57d\ud488\uc758 \uc801\uc751\uc99d \ud655\ub300\ub294 \ub9e4\ucd9c \uae30\ub300\ub97c \ub192\uc774\uace0 \uc788\uc73c\uba70, \ub958\ub9c8\ud2f0\uc2a4 \uad00\uc808\uc5fc, \uac74\uc120, \uc5fc\uc99d\uc131 \uc7a5 \uc9c8\ud658 \ub4f1 3\ucc9c\ub9cc \uba85 \uc774\uc0c1\uc758 \ubbf8\uad6d \ud658\uc790\ub4e4\uc5d0\uac8c \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc81c\ud615 \ubc0f \ud53c\ud558 \uc8fc\uc0ac \uc7a5\uce58\ub294 \ud658\uc790 \ud3b8\uc758\uc131\uc744 \uac1c\uc120\ud558\uc5ec \uc7ac\ud0dd \uc0ac\uc6a9\uc744 \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc0ac\uc774\ud1a0\uce74\uc778 \uae30\ubc18 \uba74\uc5ed \uce58\ub8cc\uc81c\ub97c \ud65c\uc6a9\ud55c \uc885\uc591\ud559 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 (+1.5% CAGR \uc601\ud5a5): \uc0ac\uc774\ud1a0\uce74\uc778\uc740 \ubcf4\uc870 \uc694\ubc95\uc5d0\uc11c 1\ucc28 \uc885\uc591\ud559 \uce58\ub8cc\ub85c \uc804\ud658\ub418\uace0 \uc788\uc73c\uba70, \uc885\uc885 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ub610\ub294 CAR-T \uce58\ub8cc\uc81c\uc640 \ubcd1\uc6a9\ub429\ub2c8\ub2e4. mRNA \uc778\ucf54\ub529 \uc0ac\uc774\ud1a0\uce74\uc778(\uc608: BNT152, mRNA-2752)\uc740 \uc885\uc591 \ub0b4 \uc804\ub2ec\uc744 \ud1b5\ud574 \uc804\uc2e0 \ub178\ucd9c\uc744 \uc81c\ud55c\ud558\uace0 \uad6d\uc18c \uba74\uc5ed \uc138\ud3ec\ub97c \ud65c\uc131\ud654\ud558\uba70, \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8 \uc81c\uc870 \uacfc\uc815\uc744 \ub2e8\ucd95\uc2dc\ucf1c \uc0dd\uc0b0 \uc8fc\uae30\ub97c \uba87 \ub2ec\uc5d0\uc11c \uba87 \uc8fc\ub85c \uc904\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc7ac\uc870\ud569 \uacf5\ud559 \ubc0f \ubc14\uc774\uc624\ud504\ub85c\uc138\uc2f1 \uae30\uc220 \ubc1c\uc804 (+0.9% CAGR \uc601\ud5a5): \uc77c\ud68c\uc6a9 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \ubc0f \uc5f0\uc18d \uad00\ub958 \uc2dc\uc2a4\ud15c\uc740 \uc0dd\uc0b0 \uc8fc\uae30\ub97c 40% \ub2e8\ucd95\ud558\uace0 \ubd80\ud53c\ub2f9 \uc218\uc728\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc784\ubca0\ub514\ub4dc \uacf5\uc815 \ubd84\uc11d \uae30\uc220(PAT)\uc740 pH, \uc0b0\uc18c, \uc601\uc591\ubd84\uc744 \uc2e4\uc2dc\uac04\uc73c\ub85c \ubbf8\uc138 \uc870\uc815\ud558\uc5ec \ubc30\uce58 \uc77c\uad00\uc131\uc744 \uac1c\uc120\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud06c\ub85c\ub9c8\ud1a0\uadf8\ub798\ud53c \ud601\uc2e0\uc740 \uc815\uc81c \ub2e8\uacc4\ub97c \uc904\uc5ec \uc81c\uc870 \uc6d0\uac00\ub97c \uc57d 25% \uc808\uac10\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubc1c\uc804\uc740 GMP \ub4f1\uae09 \uc0ac\uc774\ud1a0\uce74\uc778\uc758 \ubc30\uce58 \ucd9c\uc2dc\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc790\ubcf8\uc744 \ud655\ubcf4\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4.<br \/>\n*   mRNA \uc778\ucf54\ub529 \uad6d\uc18c \uc804\ub2ec \uc0ac\uc774\ud1a0\uce74\uc778 \ubcf4\uc870\uc81c \ud655\uc0b0 (+0.7% CAGR \uc601\ud5a5): mRNA \uad6c\uc870\ub294 \uc885\uc591 \ub0b4\uc5d0\uc11c \uc77c\uc2dc\uc801\uc778 \uc0ac\uc774\ud1a0\uce74\uc778 \ud384\uc2a4\ub97c \uc804\ub2ec\ud558\uc5ec \uace0\uc6a9\ub7c9 \ub2e8\ubc31\uc9c8\uacfc \uad00\ub828\ub41c \uc804\uc2e0 \ub3c5\uc131 \uc5c6\uc774 \ud56d\uc885\uc591 \uba74\uc5ed\uc744 \uac15\ud654\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. CureVac\uc758 CV8102 \ubc0f Gritstone\uc758 GRANITE \ud50c\ub7ab\ud3fc\uc740 \ucd08\uae30 \uc2dc\ud5d8\uc5d0\uc11c \uae0d\uc815\uc801\uc778 \uacb0\uacfc\ub97c \ubcf4\uc600\uc73c\uba70, \uaddc\uc81c \uacbd\ub85c\uac00 \uba85\ud655\ud574\uc9c0\uba74 \ube60\ub978 \uc2b9\uc778\uc774 \uac00\ub2a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870\ub97c \uc704\ud55c GMP \ub4f1\uae09 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\uc694 \uc99d\uac00 (+1.3% CAGR \uc601\ud5a5): \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc740 \uace0\ud488\uc9c8 \uc0ac\uc774\ud1a0\uce74\uc778\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uc9c1\uc811\uc801\uc73c\ub85c \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ucd5c\ucd08\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c FDA\/EMA \uc2b9\uc778 \uc99d\uac00 (+0.8% CAGR \uc601\ud5a5): \uc0c8\ub85c\uc6b4 \uc0ac\uc774\ud1a0\uce74\uc778 \uce58\ub8cc\uc81c\uc758 \uc2b9\uc778\uc740 \uc2dc\uc7a5\uc5d0 \uc0c8\ub85c\uc6b4 \ud65c\ub825\uc744 \ubd88\uc5b4\ub123\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ub192\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \ubcf5\uc7a1\ud55c \uc815\uc81c \uc694\uad6c \uc0ac\ud56d (-0.8% CAGR \uc601\ud5a5): \uc7ac\uc870\ud569 \uc0ac\uc774\ud1a0\uce74\uc778\uc740 \uace0\uac00\uc758 \ud3ec\uc720\ub958 \ubc1c\ud604 \uc2dc\uc2a4\ud15c\uacfc \ub9ac\ud130\ub2f9 500~1,200\ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ubb34\ud608\uccad \ubc30\uc9c0\ub97c \uc0ac\uc6a9\ud558\uba70, \ub2e4\ub2e8\uacc4 \ud06c\ub85c\ub9c8\ud1a0\uadf8\ub798\ud53c\ub294 \uc778\ud130\ub8e8\ud0a8-2\uc758 \uc81c\uc870 \uc6d0\uac00\ub97c \uadf8\ub7a8\ub2f9 8,000~12,000\ub2ec\ub7ec\ub85c \ub192\uc785\ub2c8\ub2e4. \uc774\ub294 \uc18c\uaddc\ubaa8 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc9c4\uc785\uc744 \uc5b4\ub835\uac8c \ud558\uace0 \ud601\uc2e0\uc744 \uc790\ubcf8\uc774 \ud48d\ubd80\ud55c \uae30\uc5c5\uc5d0 \uc9d1\uc911\uc2dc\ud0a4\ub294 \uacbd\ud5a5\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc6a9\ub7c9 \uc81c\ud55c \ub3c5\uc131\uc73c\ub85c \uc778\ud55c \uc5c4\uaca9\ud55c \uaddc\uc81c \uc2ec\uc0ac (-0.6% CAGR \uc601\ud5a5): \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \ubc0f \ubaa8\uc138\ud608\uad00 \ub204\ucd9c\uc740 \uace0\uac15\ub3c4 \uc0ac\uc774\ud1a0\uce74\uc778 \uce58\ub8cc\uc758 \uc8fc\uc694 \uc548\uc804\uc131 \ubb38\uc81c\uc785\ub2c8\ub2e4. \ud1a0\uc2e4\ub9ac\uc8fc\ub9d9(Tocilizumab) \uad6c\uc81c \uc694\ubc95\uc740 CAR-T \uc8fc\uc785 \uc2dc \ud544\uc218\uc801\uc774\uba70 \ud658\uc790\ub2f9 3,000~5,000\ub2ec\ub7ec\uc758 \ucd94\uac00 \ube44\uc6a9\uc744 \ubc1c\uc0dd\uc2dc\ud0b5\ub2c8\ub2e4. \uc5c4\uaca9\ud55c \uc704\ud5d8 \ud3c9\uac00 \ubc0f \uc644\ud654 \uc804\ub7b5(REMS)\uc740 \uc9c0\uc5ed \uc0ac\ud68c \ubcd1\uc6d0\uc758 \ucc44\ud0dd\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\uc7c1\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15 (-1.0% CAGR \uc601\ud5a5): \uae30\uc874 \uc0ac\uc774\ud1a0\uce74\uc778 \uc81c\ud488\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc\uc640 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uc2dc\uc7a5 \uc9c4\uc785\uc740 \uac00\uaca9 \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ud0a4\uace0 \uae30\uc5c5\uc758 \uc218\uc775\uc131\uc744 \uc555\ubc15\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc77c\ud68c\uc6a9 \ubc14\uc774\uc624\ud504\ub85c\uc138\uc2a4 \uc18c\ubaa8\ud488\uc758 \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1 (-0.5% CAGR \uc601\ud5a5): \ud2b9\ud788 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c \uc77c\ud68c\uc6a9 \ubc14\uc774\uc624\ud504\ub85c\uc138\uc2a4 \uc18c\ubaa8\ud488\uc758 \uacf5\uae09\ub9dd \ubb38\uc81c\ub294 \uc0dd\uc0b0 \uc9c0\uc5f0 \ubc0f \ube44\uc6a9 \uc99d\uac00\ub85c \uc774\uc5b4\uc9c8 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uc81c\ud488 \uc720\ud615\ubcc4: \uc778\ud130\ub8e8\ud0a8\uc774 \ucc28\uc138\ub300 \uc131\uc7a5\uc744 \uc8fc\ub3c4<br \/>\n    *   \uc778\ud130\ub8e8\ud0a8\uc740 \ud76c\uadc0 \uc5fc\uc99d\uc131 \uc9c8\ud658 \uce58\ub8cc\uc5d0 \ub300\ud55c \uad00\uc2ec \uc99d\uac00\ub85c 9.84%\uc758 CAGR\uc744 \uae30\ub85d\ud558\uba70 \ubaa8\ub4e0 \uc81c\ud488 \uc720\ud615 \uc911 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n    *   TNF \uc81c\uc81c\ub294 2025\ub144 \uc804\uccb4 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 44.36%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\uc7c1\uc73c\ub85c \uc778\ud574 \uc560\ube0c\ube44\uc758 \ud734\ubbf8\ub77c(Humira) \ub9e4\ucd9c\uc774 2022\ub144 212\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2023\ub144 144\uc5b5 \ub2ec\ub7ec\ub85c \uac10\uc18c\ud558\ub294 \ub4f1 \uac00\uaca9 \uc555\ubc15\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc778\ud130\ud398\ub860 \ub9e4\ucd9c\uc740 \uacbd\uad6c\uc6a9 \ud56d\ubc14\uc774\ub7ec\uc2a4\uc81c\uac00 \uac04\uc5fc \uce58\ub8cc\ub97c \uc9c0\ubc30\ud558\uba74\uc11c 5\uc5b5 \ub2ec\ub7ec \ubbf8\ub9cc\uc73c\ub85c \uac10\uc18c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc870\ud608\ubaa8\uc138\ud3ec \uc131\uc7a5 \uc778\uc790(CSFs)\ub294 Zarxio \ubc0f Nivestym\uc774 2025\ub144 \ubbf8\uad6d \uc2dc\uc7a5\uc758 40%\ub97c \ucc28\uc9c0\ud558\uba70 \uc548\uc815\uc801\uc778 \ubcf4\uc870 \uc885\uc591\ud559 \ubd84\uc57c\ub97c \ud615\uc131\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   CSFs \uc678\uc758 \uc131\uc7a5 \uc778\uc790(\uc5d0\ub9ac\ud2b8\ub85c\ud3ec\uc774\uc5d0\ud2f4, PDGF, VEGF)\ub294 2024\ub144 \uc2b9\uc778\ub41c 35% \uc800\ub834\ud55c \ub2e4\ub974\ubca0\ud3ec\uc5d0\ud2f4 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc5d0 \ud798\uc785\uc5b4 10.13% \uc131\uc7a5\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n    *   \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 \uc790\uac00\uba74\uc5ed \ubc0f \uc885\uc591\ud559\uc801 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c4 \uc778\ud130\ub8e8\ud0a8-23 \ubc0f \uc778\ud130\ub8e8\ud0a8-6 \uacbd\ub85c\ub97c \ubaa9\ud45c\ub85c \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4: \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uac00\uc18d\ud654<br \/>\n    *   \uc554 \ubc0f \uc545\uc131 \uc885\uc591\uc740 2025\ub144 \uc0ac\uc774\ud1a0\uce74\uc778 \ucc98\ubc29\uc758 49.78%\ub97c \ucc28\uc9c0\ud558\uba70, \uc870\ud608\ubaa8\uc138\ud3ec \uc131\uc7a5 \uc778\uc790 \ubc0f CAR-T \uc81c\uc870\uc6a9 \uc0ac\uc774\ud1a0\uce74\uc778\uc758 \ud655\uace0\ud55c \uc0ac\uc6a9\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<br \/>\n    *   \uadf8\ub7ec\ub098 \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc740 \uad6c\uc140\ucfe0\ub9d9(guselkumab), \ub4c0\ud53c\ub8e8\ub9d9(dupilumab) \ubc0f \uae30\ud0c0 \uc778\ud130\ub8e8\ud0a8 \ud45c\uc801 \uc57d\ubb3c\uc758 \uc801\uc751\uc99d \ud655\uc7a5\uc5d0 \ud798\uc785\uc5b4 9.54%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc785\ub2c8\ub2e4. \ud604\uc7ac \ucd94\uc138\uac00 \uc9c0\uc18d\ub41c\ub2e4\uba74 2031\ub144\uc5d0\ub294 \uc790\uac00\uba74\uc5ed \uce58\ub8cc\uc6a9 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uaddc\ubaa8\uac00 \uc885\uc591\ud559 \ubd84\uc57c\ub97c \ub118\uc5b4\uc124 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uac10\uc5fc\uc131 \uc9c8\ud658 \ubd84\uc57c\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \uc0ac\uc6a9\uc740 \uce58\ub8cc\uc6a9 \ud56d\ubc14\uc774\ub7ec\uc2a4\uc81c\uac00 \uc778\ud130\ud398\ub860 \uc694\ubc95\uc744 \ub300\uccb4\ud558\uba74\uc11c \uac10\uc18c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO)\uc758 \uae09\uc99d<br \/>\n    *   \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\uc740 2025\ub144 \uc0ac\uc774\ud1a0\uce74\uc778 \uc0dd\uc0b0\ub7c9\uc758 39.77%\ub97c \uc18c\ube44\ud588\uc73c\ub098, \ubcf5\uc7a1\ud55c \ub2e8\ubc31\uc9c8 \uc0dd\uc0b0 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00\ub85c \uc778\ud574 \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO)\uc758 \uc218\uc694\ub294 10.56% \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. CRO\ub97c \ud1b5\ud55c \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \uc810\uc720\uc728\uc740 2031\ub144\uae4c\uc9c0 \ub450 \uc790\ub9bf\uc218\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n    *   Charles River \ubc0f WuXi\uc640 \uac19\uc740 CRO\ub294 2024\ub144 \uc774\ud6c4 GMP \uc0ac\uc774\ud1a0\uce74\uc778 \uc0dd\uc0b0 \ub2a5\ub825\uc5d0 2\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc744 \ud22c\uc790\ud558\uba70, \uc790\uccb4 \uc0dd\uc0b0 \uc2dc\uc124\uc774 \uc5c6\ub294 \uc138\ud3ec \uce58\ub8cc\uc81c \uac1c\ubc1c\uc0ac\ub4e4\uc758 \uc218\uc694\ub97c \ucda9\uc871\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uae30\ub2a5\ubcc4: \uc131\uc7a5 \uc778\uc790\uc758 \ubaa8\uba58\ud140 \ud655\ubcf4<br \/>\n    *   \uc804\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778\uc740 2025\ub144 \uae30\ub2a5\ubcc4 \uc218\uc694\uc758 46.24%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc5d0\ud3ec\uc5d0\ud2f4 \ubc0f \ud544\uadf8\ub77c\uc2a4\ud300\uc758 \uc811\uadfc\uc131 \ud655\ub300\ub85c \uc131\uc7a5 \ubc0f \ubd84\ud654 \uc778\uc790\ub294 10.13%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uc900\ube44\uac00 \ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \ub0b4\uc5d0\uc11c \uc810\uc9c4\uc801\uc778 \uade0\ud615 \uc7ac\uc870\uc815\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4.<br \/>\n    *   \ud56d\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778\uc740 \uac10\uc5fc \uc704\ud5d8 \uc6b0\ub824\ub85c \uc778\ud574 \uc774\uc2dd \ub0b4\uc131 \ubc0f \uc0c1\ucc98 \uce58\uc720\uc5d0\uc11c \uc5ec\uc804\ud788 \ud2c8\uc0c8 \uc5ed\ud560\uc744 \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc720\ud1b5 \ucc44\ub110\ubcc4: \uc628\ub77c\uc778 \uc57d\uad6d\uc774 \uc804\ud1b5 \ubaa8\ub378\uc744 \ud601\uc2e0<br \/>\n    *   \ubcd1\uc6d0 \uc57d\uad6d\uc740 2025\ub144 \uc0ac\uc774\ud1a0\uce74\uc778 \uc720\ud1b5\ub7c9\uc758 53.66%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc774\ub294 \uc785\uc6d0 \ud658\uc790 CAR-T \ubc0f \uace0\uc6a9\ub7c9 IL-2 \uce58\ub8cc\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4.<br \/>\n    *   \uadf8\ub7ec\ub098 \uc628\ub77c\uc778 \uc57d\uad6d\uc740 McKesson Specialty Health\uc640 \uac19\uc740 \uc720\ud1b5\uc5c5\uccb4\uc758 \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \ud655\uc7a5\uc5d0 \ud798\uc785\uc5b4 11.34%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc7ac\ud0dd \ubc30\uc1a1\uc740 \ubcd1\uc6d0\uc73c\ub85c\ubd80\ud130 \uc8fc\uc785 \ube44\uc6a9\uc744 \uc804\ud658\ud558\ub824\ub294 \ubcf4\ud5d8\uc0ac\uc758 \ubaa9\ud45c\uc640 \uc77c\uce58\ud558\uba70, \uc7ac\ud0dd \uce58\ub8cc \uc21c\uc751\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc804\uc790\uc0c1\uac70\ub798 \ud50c\ub7ab\ud3fc\uc774 \uc131\uc219\ud574\uc9d0\uc5d0 \ub530\ub77c \ud658\uc790 \uc120\ud638\ub3c4\uc640 \ubcf4\ud5d8\uc0ac \uc9c0\uce68\uc740 \ub354 \ub9ce\uc740 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubb3c\ub7c9\uc744 \uc628\ub77c\uc778\uc73c\ub85c \uc720\ub3c4\ud558\uc5ec \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc744 \uc7ac\ud3b8\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc0ac\uc774\ud1a0\uce74\uc778 \ub9e4\ucd9c\uc758 41.53%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. FDA\uc758 \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \uc6b0\uc120 \uc2ec\uc0ac \uc81c\ub3c4\ub294 \ud3c9\uade0 \uc2b9\uc778 \uae30\uac04\uc744 9\uac1c\uc6d4\ub85c \ub2e8\ucd95\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uba54\ub514\ucf00\uc5b4\uc758 2024\ub144 \uc678\ub798 CAR-T \uce58\ub8cc\uc81c \uc0c1\ud658 \uacb0\uc815\uc740 \ud658\uc790\ub2f9 5\ub9cc \ub2ec\ub7ec\ub97c \uc808\uc57d\ud558\uace0 \ud559\uc220 \ubcd1\uc6d0 \uc678\uc758 \uc811\uadfc\uc131\uc744 \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4\uc758 pan-Canadian Pharmaceutical Alliance\ub294 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec TNF \ucc28\ub2e8\uc81c \uac00\uaca9\uc744 25~40% \uc778\ud558\ud558\uc5ec \uc628\ud0c0\ub9ac\uc624 \ubc0f \ube0c\ub9ac\ud2f0\uc2dc\uceec\ub7fc\ube44\uc544 \uc8fc\uc5d0\uc11c \uc804\ud658\uc728\uc744 \uac00\uc18d\ud654\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 10.79%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc740 2024\ub144\uc5d0 \uc644\ud654\ub41c \uaddc\uc81c(\uc678\uad6d \ub370\uc774\ud130 \ud5c8\uc6a9 \ubc0f \ud604\uc9c0 3\uc0c1 \uc784\uc0c1 \uba74\uc81c) \ud558\uc5d0 18\uac1c\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ub97c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\ub294 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\ucd9c \uc81c\uc870 \ud655\ub300\ub97c \uc704\ud574 2\uc5b5 \ub2ec\ub7ec\ub97c \ubc30\uc815\ud558\uc5ec \uacf5\uae09 \ubcd1\ubaa9 \ud604\uc0c1\uc5d0 \uc9c1\uba74\ud55c \uc11c\uad6c \uace0\uac1d\uc744 \uc720\uce58\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc2ec\uc0ac\ub97c ICH \uac00\uc774\ub4dc\ub77c\uc778\uc5d0 \ub9de\ucdb0 \uae30\uac04\uc744 16\uac1c\uc6d4\ub85c \ub2e8\ucd95\ud588\uc73c\uba70, \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4 \ubc0f \uc140\ud2b8\ub9ac\uc628\uc73c\ub85c\ubd80\ud130 12\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ud22c\uc790\ub97c \uc720\uce58\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: 2025\ub144 \ub9e4\ucd9c\uc758 28%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ub3c5\uc77c, \ud504\ub791\uc2a4, \uc601\uad6d\uc5d0 \uc9d1\uc911\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. EMA \uc9c0\uce68\uc740 \ud558\ub098\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc5f0\uad6c\ub85c \ubaa8\ub4e0 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \uc2b9\uc778\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc544\ub2ec\ub9ac\ubb34\ub9d9 \ubc0f \uc778\ud50c\ub9ad\uc2dc\ub9d9 \ubcf5\uc81c\uc57d\uc758 \ub2e4\uc911 \ub77c\ubca8 \uc9c4\uc785\uc744 \uc6a9\uc774\ud558\uac8c \ud569\ub2c8\ub2e4. \ub3c5\uc77c\uc740 TNF \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc5d0 \ub300\ud574 80%\uc758 \ucc98\ubc29 \ud560\ub2f9\ub7c9\uc744 \uc2dc\ud589\ud558\uc5ec 2025\ub144\uae4c\uc9c0 \uc624\ub9ac\uc9c0\ub110 \uc758\uc57d\ud488\uc758 \uc810\uc720\uc728\uc744 18%\ub85c \ub0ae\ucdc4\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uc2dc\uc7a5: \ube0c\ub77c\uc9c8, \ub0a8\uc544\ud504\ub9ac\uce74, \uac78\ud504 \uad6d\uac00\ub4e4\uc774 \uc2e0\ud765 \uad6c\ub9e4\uc790\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube0c\ub77c\uc9c8\uc758 \ubb3c\ub7c9 \uae30\ubc18 \uacc4\uc57d\uc740 \uc0ac\uc774\ud1a0\uce74\uc778 \uac00\uaca9\uc744 \uc808\ubc18\uc73c\ub85c \ub0ae\ucdb0 \uacf5\uacf5 \uc2dc\uc2a4\ud15c\uc758 \ubcf4\uc7a5 \ubc94\uc704\ub97c \ud655\ub300\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 \uc0c1\uc704 5\uac1c \uae30\uc5c5(AbbVie, Amgen, Novartis, Pfizer \ub4f1)\uc774 2025\ub144 \ub9e4\ucd9c\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc744 \ucc28\uc9c0\ud558\ub294 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\ub294 \ud1b5\ud569\ub41c \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uc9c4\uc785\uc740 \ud2b9\ud788 TNF \ubc0f IL-6 \ubd80\ubb38\uc5d0\uc11c \uc810\uc720\uc728\uc744 \ubd84\ud560\ud558\uace0 \uc788\uc73c\uba70, \uc774\uc5d0 \ub530\ub77c \uae30\uc874 \uae30\uc5c5\ub4e4\uc740 \uc218\uba85 \uc8fc\uae30\ub97c \uc5f0\uc7a5\ud558\uae30 \uc704\ud574 \ud53c\ud558 \uc8fc\uc0ac, \uace0\ub18d\ub3c4 \ubc0f \ubcf5\ud569 \uc81c\ud615\uc5d0 \ud22c\uc790\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 10\ub9cc \uba85 \ubbf8\ub9cc\uc758 \uc778\uad6c\ub97c \uac00\uc9c4 \ud76c\uadc0 \uc5fc\uc99d\uc131 \uc9c8\ud658\uc740 \uc2e0\uc18d \uc2b9\uc778\uc744 \ud1b5\ud574 \uc18c\ub7c9\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9\uc744 \ucc45\uc815\ud560 \uc218 \uc788\ub294 \uace0\ubd80\uac00\uac00\uce58 \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \ud615\uc131\ud569\ub2c8\ub2e4.<\/p>\n<p>BioNTech \ubc0f Moderna\uc758 mRNA \ud50c\ub7ab\ud3fc\uc740 2030\ub144\uae4c\uc9c0 \uc885\uc591\ud559 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\uc694\uc758 10~15%\ub97c \ucc28\uc9c0\ud560 \uc218 \uc788\uc73c\uba70, \uc774\ub294 \uacbd\uc7c1 \uad6c\ub3c4\ub97c \uc7ac\ud3b8\ud560 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. Amgen\uc758 2024\ub144 Teneobio \uc778\uc218\ub294 \uc81c\uc870\ub97c \ub2e8\uc21c\ud654\ud558\uace0 \ud3b8\ub9ac\ud55c \ud22c\uc5ec\ub97c \uc9c0\uc6d0\ud558\ub294 \uc911\uc1c4 \ub2e8\ub3c5 \ud56d\uccb4 \ud50c\ub7ab\ud3fc\uc744 \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4. Roche\ub294 IL-2\ub97c \uc885\uc591 \ud56d\uc6d0\uc5d0 \uc5f0\uacb0\ud558\uc5ec \ud65c\uc131\ud654\ub97c \uc545\uc131 \uc870\uc9c1\uc5d0 \uad6d\ud55c\uc2dc\ud0a4\ub294 \uc774\uc911 \ud2b9\uc774\uc131 \uc0ac\uc774\ud1a0\uce74\uc778\uc5d0 \ub300\ud55c 14\uac1c\uc758 \ud2b9\ud5c8\ub97c 2024\ub144\uc5d0 \ucd9c\uc6d0\ud588\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc555\ub825\uc774 \uc99d\uac00\ud568\uc5d0 \ub530\ub77c, \ucc28\ubcc4\ud654\ub294 \uc804\ub2ec \uae30\uc220, \uc548\uc804\uc131 \ud5a5\uc0c1 \ubc0f \uc81c\uc870 \ubbfc\ucca9\uc131\uc5d0 \ub2ec\ub824 \uc788\uc73c\uba70, \uc774\ub294 \ubbf8\ub798 \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc758 \uada4\uc801\uc744 \ud615\uc131\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 12\uc6d4: Bristol Myers Squibb\uc758 Breyanzi\uac00 \uc7ac\ubc1c\uc131 \ub610\ub294 \ubd88\uc751\uc131 \ubcc0\uc5f0\ubd80 \ub9bc\ud504\uc885\uc5d0 \ub300\ud55c 1\ud68c\uc131 CD19 CAR-T \uc8fc\uc785\uc81c\ub85c FDA \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 10\uc6d4: FDA\ub294 3\ub2e8\uacc4 1\ud615 \ub2f9\ub1e8\ubcd1 \uc9c4\ud589\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\ub294 Tzield\uc5d0 \ub300\ud55c \uc2e0\uc18d \uc2ec\uc0ac sBLA\ub97c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 8\uc6d4: Celltrion\uc740 \uc131\uc778 \ubc0f 2\uc138 \uc774\uc0c1 \uc18c\uc544\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70\uc5d0 \ub300\ud55c AVTOZMA IV (tocilizumab-anoh)\uc758 \uc801\uc751\uc99d \ud655\ub300\ub85c FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 7\uc6d4: Regeneron\uc740 \uace0\ub3c4\ub85c \uc804\ucc98\ub9ac\ub41c \ub2e4\ubc1c\uc131 \uace8\uc218\uc885\uc5d0 \ub300\ud55c Lynozyfic\uc758 \uac00\uc18d FDA \uc2b9\uc778\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uba74\uc5ed \ubc18\uc751, \uc5fc\uc99d, \uc138\ud3ec \uc131\uc7a5 \ubc0f \ubc1c\ub2ec\uc744 \uc870\uc808\ud558\ub294 \uc138\ud3ec \uac04 \uc2e0\ud638 \uc804\ub2ec \ub2e8\ubc31\uc9c8\uc778 \uc0ac\uc774\ud1a0\uce74\uc778(Cytokine) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc5f0\uad6c\ub294 \uc2dc\uc7a5 \uc815\uc758, \uc5f0\uad6c \ubc29\ubc95\ub860, \uc2dc\uc7a5 \uac1c\uc694, \ub3d9\uc778, \uc81c\uc57d \uc694\uc778, \uac00\uce58\/\uacf5\uae09\ub9dd \ubd84\uc11d, \uae30\uc220 \ubc0f \uaddc\uc81c \ud658\uacbd, \uadf8\ub9ac\uace0 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\uae00\ub85c\ubc8c \uc0ac\uc774\ud1a0\uce74\uc778 \uc2dc\uc7a5\uc740 2026\ub144 1,061\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 7.08%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uc5ec 1,494\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc138\ubd84\ud654:<br \/>\n\uc2dc\uc7a5\uc740 \uc81c\ud488 \uc720\ud615, \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c, \ucd5c\uc885 \uc0ac\uc6a9\uc790, \uae30\ub2a5, \uc720\ud1b5 \ucc44\ub110 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud488 \uc720\ud615\ubcc4: \uc778\ud130\ub8e8\ud0a8(Interleukins), \uc885\uc591 \uad34\uc0ac \uc778\uc790(TNF), \uc778\ud130\ud398\ub860(Interferons), \uc9d1\ub77d \uc790\uadf9 \uc778\uc790(CSFs), \ucf00\ubaa8\uce74\uc778(Chemokines), \uc131\uc7a5 \uc778\uc790(Growth Factors)\ub85c \ub098\ub269\ub2c8\ub2e4. \uc774 \uc911 \uc778\ud130\ub8e8\ud0a8 \uc81c\ud488\uc740 2031\ub144\uae4c\uc9c0 9.84%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4: \uc554 \ubc0f \uc545\uc131 \uc885\uc591, \uc790\uac00\uba74\uc5ed \uc9c8\ud658, \uac10\uc5fc\uc131 \uc9c8\ud658, \uc5fc\uc99d\uc131 \uc9c8\ud658 \ubc0f \uae30\ud0c0 \ubd84\uc57c\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00, \ubcd1\uc6d0 \ubc0f \uc9c4\ub2e8 \uc5f0\uad6c\uc18c, \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00(CRO)\uc73c\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4.<br \/>\n*   \uae30\ub2a5\ubcc4: \uc804\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778, \ud56d\uc5fc\uc99d\uc131 \uc0ac\uc774\ud1a0\uce74\uc778, \uc131\uc7a5 \ubc0f \ubd84\ud654 \uc778\uc790\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4.<br \/>\n*   \uc720\ud1b5 \ucc44\ub110\ubcc4: \ubcd1\uc6d0 \uc57d\uad6d, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uc18c\ub9e4 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d\uc73c\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc628\ub77c\uc778 \ucc44\ub110\uc740 \uac1c\uc120\ub41c \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \ubc0f \uc7ac\ud0dd \ubc30\uc1a1 \uc120\ud638\ub3c4 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 11.34%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uad11\ubc94\uc704\ud558\uac8c \ubd84\uc11d\ub418\uba70, \uc804 \uc138\uacc4 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ub3d9\ud5a5\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\ub85c \uac04\uc18c\ud654, \uc778\ub3c4\uc758 \uc0c8\ub85c\uc6b4 \uc778\uc13c\ud2f0\ube0c, \ud55c\uad6d\uc758 \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300 \ub4f1\uc5d0 \ud798\uc785\uc5b4 10.79%\uc758 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc774 \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\ub9cc\uc131 \ubc0f \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \uc0ac\uc774\ud1a0\uce74\uc778 \uae30\ubc18 \uba74\uc5ed\uce58\ub8cc\uc81c\ub97c \ud65c\uc6a9\ud55c \ud56d\uc554\uc81c \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5, \uc7ac\uc870\ud569 \uacf5\ud559 \ubc0f \uc0dd\ubb3c\uacf5\uc815 \uae30\uc220 \ubc1c\uc804, mRNA \uae30\ubc18 \uad6d\uc18c \uc804\ub2ec \uc0ac\uc774\ud1a0\uce74\uc778 \ubcf4\uc870\uc81c\uc758 \uc778\uae30 \uc0c1\uc2b9, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870\ub97c \uc704\ud55c GMP \ub4f1\uae09 \uc0ac\uc774\ud1a0\uce74\uc778 \uc218\uc694 \uc99d\uac00, \ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \ucd5c\ucd08\uc758 \uc0ac\uc774\ud1a0\uce74\uc778 \uce58\ub8cc\uc81c FDA\/EMA \uc2b9\uc778 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\ub192\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \ubcf5\uc7a1\ud55c \uc815\uc81c \uc694\uad6c\uc0ac\ud56d, \uc6a9\ub7c9 \uc81c\ud55c \ub3c5\uc131\uc73c\ub85c \uc778\ud55c \uc5c4\uaca9\ud55c \uaddc\uc81c \uc2ec\uc0ac, \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\uc7c1\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15, \uc77c\ud68c\uc6a9 \uc0dd\ubb3c\uacf5\uc815 \uc18c\ubaa8\ud488\uc758 \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uae30\uc220 \ubc0f \uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \uae30\uc220\uc801 \uc804\ub9dd\uacfc \uaddc\uc81c \ud658\uacbd\uc744 \ubd84\uc11d\ud558\uba70, AbbVie, Amgen, Novartis, Pfizer, Thermo Fisher Scientific \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc758 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728, \uae30\uc5c5 \ud504\ub85c\ud544 \ubc0f \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>6. \uc8fc\uc694 \ud1b5\ucc30 \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\nmRNA \ud50c\ub7ab\ud3fc\uc740 \uc0ac\uc774\ud1a0\uce74\uc778 \uc0dd\uc0b0 \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uba74\uc5ed \ud65c\uc131\ud654\ub97c \uad6d\uc18c\ud654\ud558\uc5ec, \uc784\uc0c1 \uc2dc\ud5d8 \uc131\uacf5 \uc2dc 2030\ub144\uae4c\uc9c0 \ud56d\uc554\uc81c \uc2dc\uc7a5\uc758 10~15%\ub97c \ucc28\uc9c0\ud560 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd, \ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-31682","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/31682"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=31682"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/31682\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=31682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=31682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=31682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}